Your search for inflammatory bowel disease returned 229 results

Given that immunogenicity to biologics may contribute to IBD treatment failure, the study authors sought to determine the rate of ADA formation to individual biologic agents.

Investigators assessed trends in corticosteroid use in patients with IBD over a period of 20 years.

Unlike phosphate binders, tenapanor decreases paracellular phosphate absorption in the intestine.

Higher risk for developing IBD associated with higher intake of ultra-processed foods, such as soft drinks, salty snacks, processed meat

Current research indicates that short-term utilization of an LFD may help ameliorate some mild IBS symptoms associated with quiescent IBD, while further long term studies are still needed.

Antibody concentrations lower in infliximab-treated individuals with IBD receiving single dose of BNT162b2 or ChAdOx1 nCoV-19 vaccine

Patients with IBD were compared to control groups without IBD, which included 14 completely vaccinated healthcare workers and 29 vaccinated healthy volunteers.

Concomitant immunomodulator use further blunted antibody responses to SARS-CoV-2 among infliximab-treated IBD patients

Researchers evaluated the potential predictive characteristics of eosinophilic esophagitis following IBD diagnosis in children.

The double-blind, placebo and active-controlled POETYK PSO-2 trial included 1022 patients 18 years of age and older with moderate to severe plaque psoriasis.